Overview:
- The number of uninsured patients is on the rise, with many Americans hesitating to get elective surgeries due to financial worries, impacting the profitability of Community Health Systems (CHS).
- On Thursday, CHS executives reported that their second-quarter financial results fell short of expectations, attributed to an increase in uninsured patients seeking care and a decline in surgeries. As a result, they have lowered their projections for sales and profits for 2026.
- Executives believe the uptick in uninsured patients correlates with individuals exiting Affordable Care Act exchanges following a spike in insurance premiums. CHS now anticipates adjusted earnings losses ranging from $50 million to $75 million this year, a significant increase from the earlier estimate of $20 million to $30 million.
Insight:
The recent expiration of ACA tax credits is pushing major U.S. hospital operators to reevaluate their financial standings, leaving executives navigating uncertain consequences for investors.
The anticipated financial results for the second quarter are critical; they provide insight into future trends. The reduction in ACA exchange memberships is negatively impacting healthcare providers and the overall economy.
Expectations were heightened last week when HCA Healthcare announced that it foresaw revenue losses exceeding $1 billion due to the rising number of uninsured patients, many of whom dropped their ACA plans. This news has led to stagnation or declines in the stock prices of major hospital operators.
CHS has joined the ranks of significant healthcare providers reporting increased financial losses stemming from a surge in uninsured patients after losing ACA coverage.
Following extensive congressional discussions last year, Republicans rejected extending the premium tax credit for ACA plans, resulting in skyrocketing premiums. Consequently, some Americans have abandoned their insurance plans altogether, leading to higher out-of-pocket expenses or no coverage at all.
Executives at CHS, which manages or oversees 60 hospitals and over 800 care facilities across a dozen states, noted that uncompensated patient numbers are up by around 20% compared to 2025, with a more rapid increase observed in the second quarter.
The surge in uninsured patients, especially those who left ACA plans, appears to be a significant factor influencing this rise, according to executives.
“The increase in uninsured seems mainly driven by our exchange business,” stated CEO Kevin Hammons during a call with investors.
These uninsured individuals are negatively impacting CHS’s finances. For instance, while adjusted hospitalizations grew by 2.9% year over year, over half of that surge was attributed to uninsured patients. This cohort generates minimal or no revenue, almost nullifying the hospitalization increase noted in the second quarter.
Moreover, the number of elective surgeries conducted in the second quarter has also declined, as more patients are opting out for financial reasons, particularly within orthopedics and cardiac surgeries. While same-store surgeries remained relatively stable, inpatient surgeries saw a 3.8% decrease.
Consequently, CHS has adjusted its sales and profit expectations for the year downward, anticipating operating revenue of between $11.4 billion and $11.6 billion, reduced from an initial estimate of $11.6 billion to $12 billion.
EBITDA is now projected to be between $1.3 billion and $1.375 billion, a decline from an earlier estimate of $1.34 billion to $1.49 billion.
“It feels prudent to be more cautious about the latter half of the year, so we’ve adjusted our full-year outlook,” Hammons noted.
